DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

PEG-Intron (Peginterferon Alfa-2B) - Malaise - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Malaise (104)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include malaise. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 104   Next >>

Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Drug Eruption, Haemoglobin Decreased, Malaise, Hyperglycaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-17

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-17
    End date: 2012-06-13

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-14
    End date: 2012-06-28

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-07-18
    End date: 2012-07-26

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-17
    End date: 2012-05-25

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral

Other drugs received by patient: Motilium; Gasmotin; Diflorasone Diacetate; Nizatidine



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-27

Patient:

Reactions: Product Quality Issue, Abdominal Discomfort, Malaise, Pneumonia, Nasopharyngitis, Vomiting, Bronchitis, Cough

Drug(s) suspected as cause:
PEG-Intron

Other drugs received by patient: Lisinopril; Seroquel



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Malaise, Renal Impairment, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, unk
    Indication: Hepatitis C
    Start date: 2012-06-06

Rebetol
    Dosage: 600 mg, unk
    Administration route: Oral
    Start date: 2012-06-15
    End date: 2012-06-20

Rebetol
    Dosage: 200 mg, unk
    Administration route: Oral
    Start date: 2012-06-21
    End date: 2012-07-12

Rebetol
    Dosage: 800 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-06
    End date: 2012-06-14

Rebetol
    Dosage: 200 mg, qod
    Administration route: Oral
    Start date: 2012-07-13

Telavic
    Dosage: 1500 mg, unk
    Administration route: Oral
    Start date: 2012-06-08

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-06
    End date: 2012-06-07

Other drugs received by patient: Lendormin; Lansoprazole; Amoban



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Malaise

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100 microgram per kilogram, unk
    Indication: Hepatitis C
    Start date: 2012-06-15
    End date: 2012-07-13

Rebetol
    Dosage: 800 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-15

Rebetol
    Dosage: 400 mg, unk
    Administration route: Oral
    Start date: 2012-07-06
    End date: 2012-07-13

Telavic
    Dosage: 2250 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-15

Telavic
    Dosage: 1500 mg, unk
    Administration route: Oral
    Start date: 2012-07-06
    End date: 2012-07-13

Other drugs received by patient: Diflunisal; Januvia; Basen



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-25

Patient:

Reactions: Weight Increased, Dysgeusia, Malaise, Hepatitis C, DRY Mouth

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-09-10
    End date: 2012-03-24

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-09-10
    End date: 2012-03-30

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-10-19
    End date: 2012-03-30



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Hepatitis C, Nausea, Anaemia, Rash, Headache, Dysgeusia, Irritability, Pruritus Generalised, Poor Quality Sleep, Malaise, Fatigue, Depression, Depressed Mood, Hypersomnia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.5 ml, unk
    Indication: Hepatitis C
    Start date: 2012-04-13

PEG-Intron
    Dosage: 0.4 ml, unk

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-13

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-11



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Pruritus, Hypersensitivity, Contusion, Chills, Headache, Herpes Zoster, Vascular Injury, Fatigue, Malaise, Tongue Disorder, Candidiasis, Scratch, Swelling Face, Vomiting, Tongue Oedema, Nausea, Anaemia, Hypoaesthesia, Rash, Dysgeusia, Diarrhoea, Feeling Abnormal, Influenza

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-05-04

Rebetol
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-05-04

Valtrex
    Dosage: unk unk, unknown
    Indication: Herpes Zoster

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-06-01



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient:

Reactions: Weight Decreased, non-Consummation, Fatigue, Malaise, RED Blood Cell Count Decreased, White Blood Cell Count Decreased, Vein Disorder, Vomiting, Nausea, Anaemia, Hypoaesthesia, Mental Impairment, Diarrhoea, Alopecia, Feeling Abnormal, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-09-08
    End date: 2012-08-09

Ribavirin
    Dosage: unk unk, unknown
    Start date: 2011-09-08
    End date: 2012-08-09

Other drugs received by patient: Telaprevir



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Drug Eruption, Haemoglobin Decreased, Malaise, Hyperglycaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-17

Rebetol
    Administration route: Oral

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-17
    End date: 2012-06-13

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-14
    End date: 2012-06-28

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-17
    End date: 2012-05-25

Telavic
    Dosage: 1500 mg, once
    Administration route: Oral
    Start date: 2012-07-18
    End date: 2012-07-26

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral

Other drugs received by patient: Gasmotin; Nizatidine; Motilium



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Malaise, Anaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-07-10

Rebetol
    Administration route: Oral
    Start date: 2012-05-15
    End date: 2012-05-28

Rebetol
    Administration route: Oral
    Start date: 2012-04-17

Rebetol
    Administration route: Oral
    Start date: 2012-05-29

Rebetol
    Administration route: Oral
    Start date: 2012-02-22
    End date: 2012-04-16

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-01-30

Rebetol
    Administration route: Oral
    Start date: 2012-01-31
    End date: 2012-02-21

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-01-27

Telavic
    Administration route: Oral
    Start date: 2012-01-28
    End date: 2012-02-13

Telavic
    Administration route: Oral
    Start date: 2012-02-14
    End date: 2012-02-16

Telavic
    Administration route: Oral
    Start date: 2012-02-17
    End date: 2012-04-16



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Malaise, Nausea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-21

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-21
    End date: 2012-06-17

Rebetol
    Administration route: Oral
    Start date: 2012-06-18

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-21
    End date: 2012-06-24

Telavic
    Administration route: Oral
    Start date: 2012-06-25

Other drugs received by patient: Voltaren; Mucosta



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Malaise, Blood Urea Increased, Blood Creatinine Increased, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-06-13

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-13

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-13
    End date: 2012-07-03

Telavic
    Administration route: Oral
    Start date: 2012-07-04



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Malaise, Nausea, Anaemia, Insomnia, Depression, Rash, Constipation, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-02-22

PEG-Intron
    Dosage: 1.0mcg/kg/week
    Start date: 2012-02-29
    End date: 2012-02-29

PEG-Intron
    Dosage: 0mcg/kg

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-02-14

Rebetol
    Administration route: Oral
    Start date: 2012-02-15
    End date: 2012-03-07

Rebetol
    Administration route: Oral

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-02-28

Telavic
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-03-07

Telavic
    Administration route: Oral

Other drugs received by patient: [therapy Unspecified]; [therapy Unspecified]; Milmag; Senna-Mint WAF; [therapy Unspecified]



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Malaise

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-14
    End date: 2012-06-18

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-14
    End date: 2012-06-18

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-14
    End date: 2012-06-14

Other drugs received by patient: Allegra; Urso 250; Epinastine Hydrochloride



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-14

Patient:

Reactions: Malaise, Depression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.3mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-29

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-29

Telavic
    Administration route: Oral
    Start date: 2012-07-04

Telavic
    Administration route: Oral
    Start date: 2012-05-29
    End date: 2012-07-03

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-29

Other drugs received by patient: Olmesartan Medoxomil; Loxonin; Zolpidem; Rebamipide; Amlodipine



Possible PEG-Intron side effects in

Reported by a individual with unspecified qualification from Japan on 2012-08-14

Patient:

Reactions: Malaise

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-05-15

Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-06
    End date: 2012-05-14

Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-05-22
    End date: 2012-05-24

PEG-Intron
    Dosage: 50mcg
    Start date: 2012-06-06

PEG-Intron
    Dosage: 60 mcg/week
    Indication: Hepatitis C
    Start date: 2012-04-06
    End date: 2012-05-02

PEG-Intron
    Dosage: 50 mcg/week
    End date: 2012-05-18

PEG-Intron
    Dosage: 40 mcg/week
    Start date: 2012-05-11

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-06
    End date: 2012-04-25

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-04-26
    End date: 2012-05-07

Rebetol
    Administration route: Oral
    Start date: 2012-06-14

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    End date: 2012-05-24

Telavic
    Administration route: Oral
    Start date: 2012-05-15
    End date: 2012-05-21

Telavic
    Administration route: Oral
    Start date: 2012-05-22
    End date: 2012-05-23

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-06
    End date: 2012-05-14

Other drugs received by patient: Olmesartan Medoxomil; Olmesartan Medoxomil; Allopurinol



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-10

Patient:

Reactions: Malaise, Rash

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-08

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-08

Rebetol
    Administration route: Oral

Rebetol
    Administration route: Oral

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-08

Telavic
    Administration route: Oral
    Start date: 2012-05-08
    End date: 2012-07-11



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Weight Decreased, Stomatitis, Nausea, Pain in Extremity, Pain, Bone Pain, Oral Discomfort, Dysgeusia, Haemoglobin Decreased, Fatigue, Malaise, DRY Mouth, Decreased Appetite, Influenza Like Illness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Rebetol
    Dosage: 600 mg, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Victrelis
    Dosage: 2400 mg, unknown
    Indication: Hepatitis C
    Start date: 2012-03-07

Other drugs received by patient: Geodon; Ferrous Sulfate TAB; Ambien; Promethazine; Prozac; Prilosec



Possible PEG-Intron side effects in

Reported by a pharmacist from United States on 2012-08-10

Patient:

Reactions: Off Label Use, Drug Dose Omission, Malaise

Drug(s) suspected as cause:
PEG-Intron



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03

Patient:

Reactions: Weight Decreased, Head Injury, Teeth Brittle, Loss of Consciousness, Malaise, Fatigue, Oral Candidiasis, Hyperchlorhydria, Depression, Decreased Appetite, Hypersomnia, Tooth Fracture, Dyspnoea, Vomiting, Anaemia, Rash, Dysgeusia, Anxiety, Alopecia, Insomnia, Hypophagia, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-10-25

Ribavirin
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-10-25

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-11-23



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03

Patient:

Reactions: Contusion, Hypersensitivity, Chills, Herpes Zoster, Vascular Injury, Face Oedema, Malaise, Tongue Disorder, Candidiasis, Scratch, Vomiting, Tongue Oedema, Rash, Hypoaesthesia, Dysgeusia, Diarrhoea, Feeling Abnormal, Influenza

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-05-04

Ribavirin
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-05-04

Valtrex
    Dosage: unk unk, unknown
    Indication: Herpes Zoster

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-06-01



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-02

Patient:

Reactions: Haemoglobin Decreased, White Blood Cell Count Decreased, Dysgeusia, Malaise, Haemolytic Anaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-03-22

PEG-Intron
    Dosage: 1.5mcg/kg/week

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Start date: 2012-04-18
    End date: 2012-05-09

Rebetol
    Dosage: 400 mg, once
    Administration route: Oral
    Start date: 2012-05-11

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-22
    End date: 2012-04-17

Telavic
    Administration route: Oral
    Start date: 2012-04-18
    End date: 2012-05-09

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-22
    End date: 2012-04-17

Telavic
    Administration route: Oral
    Start date: 2012-05-11
    End date: 2012-05-22

Other drugs received by patient: Marzulene-S; Nexium; Diovan; Azunol (Sodium Gualenate); Adalat CC; Mucosta



Possible PEG-Intron side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-01

Patient: male

Reactions: Malaise, Injection Site Rash

Drug(s) suspected as cause:
PEG-Intron



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-01

Patient:

Reactions: Weight Decreased, Pruritus, Malaise, Nausea, Anaemia, Insomnia, Haemolytic Anaemia, Asthenia, Paraesthesia

Drug(s) suspected as cause:
Investigational Drug (Unspecified)
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-07-05
    End date: 2011-09-29

PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-07-05
    End date: 2011-12-01

Ribavirin
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-07-05
    End date: 2011-12-01



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-01

Patient:

Reactions: Drug Eruption, White Blood Cell Count Decreased, Depressive Symptom, Pancytopenia, Dysgeusia, Haemoglobin Decreased, Malaise, Diarrhoea, Epistaxis, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100mcg/week
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-02-24

Rebetol
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-03-05

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-02-28

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-02-28

Telavic
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-03-05

Other drugs received by patient: Marzulene-S; Mucosta; Urso 250; Famotidine



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-01

Patient:

Reactions: Malaise, Platelet Count Decreased

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-03
    End date: 2012-06-05

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-03
    End date: 2012-06-05

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-03
    End date: 2012-06-05

Other drugs received by patient: Antebate; Prednisolone; [therapy Unspecified]



Possible PEG-Intron side effects in

Reported by a pharmacist from United States on 2012-08-01

Patient:

Reactions: Product Quality Issue, Malaise, Incorrect Dose Administered

Drug(s) suspected as cause:
PEG-Intron



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-07-31

Patient:

Reactions: Malaise, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-04-15

Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-29

Paxil
    Dosage: 3 df, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Paxil
    Administration route: Oral
    Indication: Adverse Event
    Start date: 2012-02-01

PEG-Intron
    Dosage: 80mcg/week
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-01

PEG-Intron
    Dosage: 1.0mcg/kg/week
    Start date: 2012-04-16
    End date: 2012-04-30

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Start date: 2012-02-29
    End date: 2012-04-15

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Start date: 2012-05-01

PEG-Intron
    Dosage: 50mcg/week
    Start date: 2012-02-08
    End date: 2012-02-15

Peginterferon Alfa-2B
    Dosage: 1.5 ?g/kg, qw
    Start date: 2012-02-29
    End date: 2012-04-15

Peginterferon Alfa-2B
    Dosage: 1.5 ?g/kg, qw
    Start date: 2012-05-01

Peginterferon Alfa-2B
    Dosage: 1.0 ?g/kg, qw
    Start date: 2012-04-16
    End date: 2012-04-30

Peginterferon Alfa-2B
    Dosage: 50 ?g/kg, qw
    Start date: 2012-02-08
    End date: 2012-02-15

Peginterferon Alfa-2B
    Dosage: 80 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-01

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-29

Rebetol
    Administration route: Oral
    Start date: 2012-02-08
    End date: 2012-02-14

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-04-09
    End date: 2012-04-15

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-05-07
    End date: 2012-05-13

Rebetol
    Administration route: Oral
    Start date: 2012-02-15
    End date: 2012-02-29

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-05-01
    End date: 2012-05-06

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-05-14

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-03-12

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-13
    End date: 2012-04-08

Rebetol
    Administration route: Oral
    Start date: 2012-01-17
    End date: 2012-02-07

Telavic
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-04-15

Telavic
    Administration route: Oral
    Start date: 2012-02-08
    End date: 2012-02-14

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-07

Telavic
    Administration route: Oral
    Start date: 2012-02-15
    End date: 2012-02-29

Other drugs received by patient: HI-Z; [composition Unspecified]; Ganaton; Primeperani; Nizatidine; Talion (Bepotastine Besylate); Magmitt; Depas; Primeperani; Ganaton; Zolpidem; Loxonin; Dogmatyl; HI-Z



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-07-31

Patient:

Reactions: Dysgeusia, Malaise, Hypoaesthesia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-11
    End date: 2012-05-16

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-11
    End date: 2012-05-22

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-11
    End date: 2012-05-22



Possible PEG-Intron side effects in

Reported by a individual with unspecified qualification from Japan on 2012-07-31

Patient:

Reactions: Malaise, Nausea, Anaemia, Dizziness, Rash, Hyperuricaemia, Decreased Appetite

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-01

Antiviral (Unspecified)
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-06-03

PEG-Intron
    Dosage: 80 ?g, unknown
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-01

PEG-Intron
    Dosage: 80mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-06-01
    End date: 2012-06-22

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-01

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-01
    End date: 2012-06-21

Rebetol
    Administration route: Oral
    Start date: 2012-06-22
    End date: 2012-06-28

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-01
    End date: 2012-06-06

Telavic
    Administration route: Oral
    Start date: 2012-06-07
    End date: 2012-06-28

Other drugs received by patient: Levothyroxine Sodium; Levothyroxine Sodium; Lulicon; Equa; Amaryl; Metformin HCL; Aspara CA; Vitamin B12; Pravastatin



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017